[Antipsychotics in combination with central stimulants].

Area of Science:

• Pharmacology
• Clinical Medicine
• Toxicology

Background:

• Central stimulants (CS) and antipsychotics (AP) are frequently co-administered or co-ingested in clinical settings.
• Managing patients exposed to both CS and AP presents unique challenges due to complex drug interactions and overlapping toxicities.

Purpose of the Study:

• To provide a comprehensive overview of the current management strategies for acute intoxication with CS.
• To outline best practices for the administration and management of AP in patients concurrently exposed to CS.
• To address the complexities of co-exposure to CS and AP across diverse patient populations.

Main Methods:

• This review synthesizes current literature and clinical guidelines.
• Expert collaboration between psychiatrists, clinical pharmacologists, and anaesthesiologists ensured a multidisciplinary approach.
• The review focuses on state-of-the-art management of clinical scenarios involving simultaneous CS and AP exposure.

Main Results:

• The review details treatment protocols for acute CS intoxication.
• It provides specific recommendations for AP management based on patient groups and exposure levels.
• The findings highlight the importance of a coordinated, multidisciplinary approach.

Conclusions:

• Effective management of CS intoxication requires careful consideration of concurrent AP use.
• A collaborative approach involving various medical specialists is crucial for optimizing patient outcomes.
• This review serves as a valuable resource for clinicians managing complex co-exposure cases.